Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2020
2020 World Conference on Lung Cancer
Conference Program for the 2020 World Conference on Lung Cancer
Presentation Date(s):- January 28 - 31, 2021
- Total Presentations: 1597
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
FP07 - Pathology
- Type: Posters (Featured)
- Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
- Presentations: 17
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
FP07.09 - Detection of Early Lung Cancer from Average-Risk Individuals and from Benign Nodule Carriers with a DNA Methylation Blood Test
00:00 - 00:00 | Presenter: Baohui Han
- Abstract
Loading...
-
+
P14 - Immuno-biology and Novel Immunotherapeutics (Phase I and Translational) - Immuno-Biology
- Type: Posters
- Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
- Presentations: 30
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P14.29 - Toripalimab in Combination with CIK Cells in Patients with Advanced NSCLC: An Exploratory Study
00:00 - 00:00 | Presenter: Baohui Han
- Abstract
Loading...
-
+
P15 - Immuno-biology and Novel Immunotherapeutics (Phase I and Translational) - Novel Immunotherapeutics (Phase I)
- Type: Posters
- Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
- Presentations: 8
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P15.07 - Safety and Efficacy Profile of TQB-2450 Alone/with Anlotinib in Previously-Treated Advanced NSCLC: A Phase IB Single-Arm Trial
00:00 - 00:00 | Presenter: Baohui Han
- Abstract
Loading...
-
+
P26 - Mesothelioma, Thymoma and Other Thoracic Malignancies - Thymic Malignancies
- Type: Posters
- Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
- Presentations: 10
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P26.05 - Comprehensive Genomic Sequencing in Thymic Epithelial Tumors: Identification of Multiple Poor Prognosis Biomarkers in Chinese Patients
00:00 - 00:00 | Presenter: Baohui Han
- Abstract
Loading...
-
+
P46 - Screening and Early Detection - Gene-Based Risk Stratification
- Type: Posters
- Track: Screening and Early Detection
- Presentations: 7
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P46.04 - Identify Lung Adenocarcinoma among Pulmonary Micro-nodules through Blood Gene Expression Profiles
00:00 - 00:00 | Presenter: Baohui Han
- Abstract
Loading... -
+
P46.05 - A Blood Six-Gene Test for Early-Stage Lung Adenocarcinoma Screening in Asympomatic Population
00:00 - 00:00 | Presenter: Baohui Han
- Abstract
Loading...
-
+
P48 - Small Cell Lung Cancer/NET - Chemo - IO
- Type: Posters
- Track: Small Cell Lung Cancer/NET
- Presentations: 23
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P48.09 - Anlotinib Plus Etoposide and Carboplatin as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer: A Single Arm Phase II Trial
00:00 - 00:00 | Presenter: Baohui Han
- Abstract
Loading...
-
+
P62 - Tumor Biology and Systems Biology - Basic and Translational Science - Metabolomics
- Type: Posters
- Track: Tumor Biology and Systems Biology - Basic and Translational Science
- Presentations: 10
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P62.09 - PLGF Regulates Stimulation of Cell Proliferation and Glycolysis of Lung Adenocarcinoma Through Wnt/β-catenin Pathway
00:00 - 00:00 | Presenter: Baohui Han
- Abstract
Loading...
-
+
P67 - Tumor Biology and Systems Biology - Basic and Translational Science - Proteomics
- Type: Posters
- Track: Tumor Biology and Systems Biology - Basic and Translational Science
- Presentations: 1
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P67.01 - Differential Proteomics Analysis on Plasma from Anlotinib-Treated Advanced Non-Small Cell Lung Cancer Patients
00:00 - 00:00 | Presenter: Baohui Han
- Abstract
Loading...
-
+
P76 - Targeted Therapy - Clinically Focused - EGFR
- Type: Posters
- Track: Targeted Therapy - Clinically Focused
- Presentations: 98
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P76.10 - Erlotinib Plus Anlotinib as First-Line Therapy in Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations: An Open-Label, Phase 2 Study
00:00 - 00:00 | Presenter: Tianqing Chu
- Abstract
Loading... -
+
P76.59 - Rationale and Design of a Phase II Trial of Dacomitinib in Advanced NSCLC Patients with Uncommon EGFR Mutations
00:00 - 00:00 | Presenter: Baohui Han
- Abstract
Loading...
-
+
P80 - Immunotherapy (Phase II/III Trials) - Immunotherapy Plus Chemotherapy/ Immunotherapy Plus Targeted Therapy
- Type: Posters
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 1
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P80.01 - A Multicenter, Randomized, Phase 3 Trial of Penpulimab in Combination With Anlotinib or Chemotherapy as First-Line Treatment in Advanced NSCLC
00:00 - 00:00 | Presenter: Baohui Han
- Abstract
Loading...